ESC is committed to equity in eczema care
Atopic dermatitis (AD), commonly known as eczema, is a chronic and often debilitating skin condition that affects millions of Canadians. However, Indigenous communities, particularly those in remote and northern areas, face unique barriers that make managing AD even more challenging. Lack of access to dermatologists, long wait times, high costs, and limited availability of specialized treatments such as phototherapy create significant obstacles for those in need.
Eczema Society of Canada (ESC) is committed to advocating for better care and improved access to treatment for Indigenous populations affected by AD. A key partner in this effort is Dr. Rachel Asiniwasis, a board-certified dermatologist and ESC medical contributor who has dedicated her career to addressing these healthcare disparities.
Dr. Asiniwasis has spent years researching and advocating for better dermatologic care for Indigenous patients. She notes that Indigenous populations experience higher prevalence rates of AD and other atopic conditions. “Roughly 20% of the population lives in rural and remote areas, many of which are Indigenous communities. As an urban-based dermatologist in the Midwest, I often work with rural populations who face challenges in accessing healthcare, as well as limited healthcare infrastructure,” says Dr. Asiniwasis. These burdens demonstrate deep concern not only for physical health but overall mental health and well-being of individuals, families, and communities.
Since 2019, ESC has partnered with Dr. Asiniwasis on several initiatives, including pictorial-based educational resources and on-the-ground advocacy for the inclusion of newer AD therapies on the NIHB formulary. Dr. Asiniwasis adds: “We need to close gaps in this disease and promote health equity for all, regardless of location.”
ESC remains committed to driving change. In 2023, Dr. Anastasia Shamsuyarova, MD, MSc, FRCPC, received the ESC Research Grant Award for her project, Atopic Dermatitis Educational Intervention for Remote Indigenous Communities. This initiative aims to improve access to care and treatment for Indigenous patients affected by eczema.
ESC is committed to advancing equity in dermatologic care for all Canadians. To learn more about our Advocacy in Action, visit our website.
March 2026
